Identifying drug targets and evaluating KLK3-targeted inhibitors for prostate cancer using in-silico and in-vitro approaches

Miyahira AK, Sharp A, Ellis L, Jones J, Kaochar S, Larman HB, et al. Prostate cancer research: the next generation; report from the 2019 Coffey-Holden prostate cancer academy meeting. Prostate. 2020;80(2):113–32.

Article  PubMed  Google Scholar 

Gonzalez LO, Eiro N, Fraile M, Beridze N, Escaf AR, Escaf S, et al. Prostate cancer tumor stroma: responsibility in tumor biology, diagnosis and treatment. Cancers. 2022;14(18):4412.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Poppel H, Roobol MJ, Chapple CR, Catto JW, N’Dow J, Sønksen J, et al. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021. Eur Urol. 2021;80(6):703–11.

Article  PubMed  Google Scholar 

Hassanipour S, Delam H, Arab-Zozani M, Abdzadeh E, Hosseini SA, Nikbakht HA, et al. Survival rate of prostate cancer in Asian countries: a systematic review and meta-analysis. Ann Glob Health. 2020;86(1):2.

Article  PubMed  PubMed Central  Google Scholar 

Baskaran S, Selvam MKP, Agarwal A. Exosomes of male reproduction. Adv Clin Chem. 2020;95:149–63.

Article  CAS  PubMed  Google Scholar 

Kandalan RN, Nguyen D, Rezaeian NH, Barragán-Montero AM, Breedveld S, Namuduri K, et al. Dose prediction with deep learning for prostate cancer radiation therapy: model adaptation to different treatment planning practices. Radiother Oncol. 2020;153:228–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habib A, Jaffar G, Khalid MS, Hussain Z, Zainab SW, Ashraf Z, et al. Risk factors associated with prostate cancer. J Drug Deliv Ther. 2021;11(2):188–93.

Article  CAS  Google Scholar 

Wasim S, Lee SY, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022;23(22):14257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, Golubnitschaja O. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11(3):399–418.

Article  PubMed  PubMed Central  Google Scholar 

Berenguer CV, Pereira F, Câmara JS, Pereira JA. Underlying features of prostate cancer—statistics, risk factors, and emerging methods for its diagnosis. Curr Oncol. 2023;30(2):2300–21.

Article  PubMed  PubMed Central  Google Scholar 

Williams IS, McVey A, Perera S, O’Brien JS, Kostos L, Chen K, et al. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022;217(8):424–33.

Article  PubMed  PubMed Central  Google Scholar 

Yan Y, Yeon SY, Qian C, You S, Yang W. On the road to accurate protein biomarkers in prostate cancer diagnosis and prognosis: current status and future advances. Int J Mol Sci. 2021;22(24):13537.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kouspou MM, Fong JE, Brew N, Hsiao ST, Davidson SL, Choyke PL, et al. The movember prostate cancer landscape analysis: an assessment of unmet research needs. Nat Rev Urol. 2020;17(9):499–512.

Article  PubMed  PubMed Central  Google Scholar 

Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, Guy M, et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet. 2011;129(6):687–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, et al. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis. 2011;32(6):853–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zafar I, Anwar S, Yousaf W, Nisa FU, Kausar T, ul Ain Q, et al. Reviewing methods of deep learning for intelligent healthcare systems in genomics and biomedicine. Biomed Signal Process Control. 2023;86:105263.

Article  CAS  Google Scholar 

Ahmad HM, Abrar M, Izhar O, Zafar I, Rather MA, Alanazi AM, et al. Characterization of fenugreek and its natural compounds targeting AKT-1 protein in cancer: pharmacophore, virtual screening, and MD simulation techniques. J King Saud Univ Sci. 2022;34(6):102186.

Article  Google Scholar 

Ali S, Ali U, Qamar A, Zafar I, Yaqoob M, Ain QU, et al. Predicting the effects of rare genetic variants on oncogenic signaling pathways: a computational analysis of HRAS protein function. Front Chem. 2023;11:1173624.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turnham DJ, Bullock N, Dass MS, Staffurth JN, Pearson HB. The PTEN conundrum: how to target PTEN-deficient prostate cancer. Cells. 2020;9(11):2342.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Milella M, Falcone I, Conciatori F, Incani UC, Del Curatolo A, Inzerilli N, et al. PTEN: multiple functions in human malignant tumors. Front Oncol. 2015;5:24.

Article  PubMed  PubMed Central  Google Scholar 

Shiota M (2021) Oxidative stress and prostate cancer. In: Cancer, pp 15–26. Academic Press.

Papachristodoulou A, Rodriguez-Calero A, Panja S, Margolskee E, Virk RK, Milner TA, et al. NKX3.1 localization to mitochondria suppresses prostate cancer initiation. Cancer Discov. 2021;11(9):2316–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jamaspishvili T, Berman DM, Ross AE, Scher HI, De Marzo AM, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer. Nat Rev Urol. 2018;15(4):222–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gülhan Ö, Mahi B. The role of AMACR, CD10, TMPRSS2-ERG, and p27 protein expression among different Gleason grades of prostatic adenocarcinoma on needle biopsy. Clin Med Insights Oncol. 2020;14:1179554920947322.

Article  PubMed  PubMed Central  Google Scholar 

Mkabile S, Swartz L. Caregivers’ and parents’ explanatory models of intellectual disability in Khayelitsha, Cape Town, South Africa. J Appl Res Intellect Disabil. 2020;33(5):1026–37.

Article  PubMed  Google Scholar 

Kumar BK, Faheem N, Sekhar KVGC, Ojha R, Prajapati VK, Pai A, Murugesan S. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. J Biomol Struct Dyn. 2022;40(3):1363–86.

Article  CAS  PubMed  Google Scholar 

Zafar I, Safder A, Imran Afridi H, Riaz S, -ur-Rehman R, Unar A, et al. In silico and in vitro study of bioactive compounds of Nigella sativa for targeting neuropilins in breast cancer. Front Chem. 2023;11:11273149.

Article  Google Scholar 

Mouada H, Lanez T, Zafar I. ROS scavenging, DNA binding and NADPH oxidase inhibition potential of N’-Ferrocenylmethyl-N’-phenylpropionohydrazide using cyclic voltammetry and molecular docking. J Organomet Chem. 2024;1007:123026.

Article  CAS  Google Scholar 

Bleyer A, Spreafico F, Barr R. Prostate cancer in young men: an emerging young adult and older adolescent challenge. Cancer. 2020;126(1):46–57.

Article  PubMed  Google Scholar 

Fujita K, Nonomura N. Role of androgen receptor in prostate cancer: a review. World J Mens Health. 2019;37(3):288–95.

Article  PubMed  Google Scholar 

White J. PubMed 2.0. Med Ref Serv Q. 2020;39(4):382–7.

Article  PubMed  Google Scholar 

Dave T, Athaluri SA, Singh S. ChatGPT in medicine: an overview of its applications, advantages, limitations, future prospects, and ethical considerations. Front Artif Intell. 2023;6:1169595.

Article  PubMed 

Comments (0)

No login
gif